Home
Portfolio
AbOUT
Investment Approach
History
Philanthropy
Team
NEWS
Pitch your startup
CONTACT
Apr 21, 2025
FDA Accepts Amended Protocol for Phase 3 Trial of Buntanetap in Alzheimer Disease
Related posts
Browse all posts
Healium Announces FDA Registration of Healium Clinical as a Class II 510(k)-Exempt Biofeedback Medical Device
May 22, 2026
HealthJoy's Benefits Operating System Drives 18% Savings on Medical Procedures Through Intelligent Steerage
May 22, 2026
